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Participants
A British Caucasian cohort consisting of 108 ATP cases (TEN n=84 and RUP n=24) and 131
asymptomatic controls was recruited as described in our earlier study4. Participants signed a
consent form and completed a medical and injury history questionnaire. This study was
approved by the Research Ethics Committee at the University of Northampton, United
Kingdom.
DNA Extraction and Genotyping
Saliva (2 ml) was collected from each participant using the OG-500 tubes (DNA Genotek,
Ottawa, Canada) and DNA was extracted according to the manufacturer’s
recommendations. All participants were genotyped using custom-designed TaqMan assays
technology (Applied Biosystems, Foster City, USA) for the ELN G/A rs2071307. Genotype
calls were automatically made using the Applied Biosystem StepOnePlus real-time PCR
software (Applied Biosystems, Foster City, USA).
Statistical Analyses
Population data such as genotype and allele frequencies in addition to the Hardy-Weinberg
Equilibrium were calculated using the R Genetics package. Differences in genotypic and
allelic distributions were tested using chi-squared or a Fisher’s exact test. Statistical
significance was accepted at p<0.05.
RNA Secondary Structure
The secondary RNA structures of exon 20 where the rs2071307 resides were determined
using the SFold statistical algorithm (http://sfold.wadsworth.org) . The structures were
folded in the absence of divalent ions at 37 C and at a concentration of 1 M.
There was no significant genotypic or allelic association between the ELN rs2071307 and the
risk of TEN (p=0.086, p=0.119), RUP (p=0.501, p=0.243), or when both pathologies were
combined into the ATP group (p=0.413, p=0.399) respectively (table 1). Furthermore, no
significant genotypic or allelic were reported when the dataset was split according to gender
(data not shown).
Elastin is known to display a remarkable durability following enormous stretch and recoil cycles. However, the substitution of the amino acid glycine to serine induced by the rs2071307 variant is
described to alter the mechanical properties of ELN4. We report a difference in free energy change (ΔG°) which suggests a potentially greater force driving the spontaneous forward reaction of the
A allele RNA than that of the G allele RNA5. These thermodynamic properties could explain an over-expression of ELN mRNA as observed in post-injury Achilles tendons of mice6. Although the
association of the ELN rs2071307 gene variant with soft tissue pathologies is documented in aortic stenosis and aneurysms, it appears not to be associated with the risk of ATPs in a British
Caucasian cohort. This data is consistent with the early study in Australian and South African cohorts. It should be noted however, that the sample number is small and that these findings require
replication in other ethnicities.
Table 1. Genotype and allele frequency distribution of the ELN rs2071307 variant within the UK control (CON)
and Achilles tendon pathology (ATP), as well as the pathological sub-groups Achilles tendinopathy (TEN) and
Achilles tendon rupture (RUP).
Injuries to the Achilles tendon (tendinopathies or ruptures) are considered as ones of the
most severe musculoskeletal traumas in sports with an incidence rate of 50% in athletes and
10% in the general population. A number of gene variants coding for tendon structural
proteins such as COL5A11 and FBN22 have previously been associated with Achilles tendon
pathologies (ATP). These protein along with others maintain a harmonious interaction with
elastin to allow tendons to respond to tensile load by stretching and returning to their
original lengths. The ELN rs2071307 variant has been associated with soft tissue pathologies
and is believed to be a good candidate gene as it results in the substitution of the
hydrophobic amino acid glycine with the hydrophilic serine. However, in a previous study
this variant was not associated with either Achilles tendinopathy or ACL rupture in
populations from Australia and South Africa2. As recent evidence suggests that genetic risk
factors for tendinopathy may depend, to some extent, on geographic location3, the aim of
this study was to determine whether the ELN rs2071307 variant was associated with the risk
of ATP in a British cohort.
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Figure 3. Comparison of the secondary structure of the RNA transcribed from exon 20 of the ELN gene. A)
Secondary RNA structure when the G allele is present at the rs2071307 variant. B) Secondary structure when
the A allele is present at the rs2071307 variant. The structural differences are magnified in the box, and the
alleles are highlighted by a red circle.
ELN
rs2071307
CON (n=131) ATP (n=108) TEN (n=84) RUP (n=24)
GG 38.2 (50) 39.8 (43) 42.8 (36) 29.2 (7)
GA 45.8 (60) 50.0 (54) 51.2 (43) 45.8 (11)
AA 16.0 (21) 10.2 (11) 5.9 (5) 45.0 (6)
P Value 0.413a 0.086b 0.501c
HWE 0.722 0.400 0.074 0.676
A allele 38.9 (102) 35.2 (76) 31.5 (53) 47.9 (23)
P Value 0.399a 0.119b 0.243c
The values are expressed as a frequency with the number of participants (n) in parenthesis. 
a CON vs ATP; b CON vs TEN; c CON vs RUP
We report a structural difference between the RNA secondary structure obtained from a G and 
an A allele at the rs2071307 locus. This structural difference results in altering the free energy 
of the molecule: G allele, ΔG°=-70.6 kcal/mol; A allele, ΔG°=-71.6 kcal/mol.
